PROF

Profound Medical Corp

PROF, USA

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

https://www.profoundmedical.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
PROF
stock
PROF

Responsive Playbooks and the PROF Inflection news.stocktradersdaily.com

Read more →
PROF
stock
PROF

Wall Street Analysts Think Profound Medical (PROF) Could Surge 82.37%: Read This Before Placing a Bet Yahoo Finance

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$12.1

Analyst Picks

Strong Buy

4

Buy

1

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Neutral

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

6.87

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-24.54 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-18.65 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-181.25 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.32

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 11.05% of the total shares of Profound Medical Corp

1.

Fidelity True North Cl F

(5.6234%)

since

2025/06/30

2.

Royce Micro Cap Trust

(1.4344%)

since

2025/06/30

3.

Royce Micro-Cap Invmt

(0.7768%)

since

2025/06/30

4.

Fidelity Canadian Equity Instl Tr

(0.6489%)

since

2025/07/31

5.

First Eagle Small Cap Opportunity I

(0.5498%)

since

2025/07/31

6.

First Eagle US Small Cap Strategy

(0.3569%)

since

2025/06/30

7.

PICTON Market Neutral Equity Alt F

(0.3557%)

since

2025/06/30

8.

Royce Capital Micro-Cap Inv

(0.334%)

since

2025/06/30

9.

North Growth Canadian Equity Series F

(0.2675%)

since

2025/06/30

10.

PICTON Long Short Equity Alternative F

(0.1937%)

since

2025/06/30

11.

TD Canadian Small Cap Equity - I

(0.1344%)

since

2024/12/31

12.

NEI Growth and Income A

(0.1005%)

since

2025/07/31

13.

iShares S&P/TSX Small Cap ETF

(0.0531%)

since

2025/08/31

14.

Fidelity Nasdaq Composite Index

(0.0467%)

since

2025/07/31

15.

First Eagle US Small Cap Opp I-UC

(0.0362%)

since

2025/07/31

16.

Pender Alternative Special Situations F

(0.0313%)

since

2025/08/31

17.

CI Synergy Canadian Corporate Class A

(0.0299%)

since

2024/12/31

18.

NEI Canadian Equity A

(0.0266%)

since

2025/07/31

19.

NEI Long Short Equity F

(0.0266%)

since

2025/07/31

20.

CI Synergy Global Corporate Class A

(0.014%)

since

2025/03/31

21.

Carolina Wealth Advisors, LLC

(0.0067%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-0.26

EPS Estimate

-0.398

EPS Difference

0.138

Surprise Percent

34.6734%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Fair GARP(4.5)
Growth
Weak Growth Prospect(3)
Momentum
Moderate Momentum(4)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Low Quality Business(3)
Value
Fair Value(3.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.